![logo](/logos/B8F.DE.webp)
Biofrontera AG
FSX:B8F.DE
0.31 (EUR) • At close May 13, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Biofrontera AG |
Symbool | B8F.DE |
Munteenheid | EUR |
Prijs | 6.804 |
Beurswaarde | 20,673,478 |
Dividendpercentage | 0% |
52-weken bereik | 0.296 - 22.575 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Ms. Pilar de la Huerta Martinez |
Website | https://www.biofrontera.com |
An error occurred while fetching data.
Over Biofrontera AG
Biofrontera AG, a biopharmaceutical company, engages in the research, development, and marketing of dermatological products. Its products include Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. The company also develops RhodoLED XL for
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (EUR)
Cijfers zijn in miljoenen (EUR)